Medicare Enrolled

Dr. Mark Mitchell, M.D.

Radiation Oncology · Oxnard, CA
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Low-engagement
2001 N. SOLAR DR., SUITE 135, Oxnard, CA 93036
8059880616
In practice since 2007 (18 years)
NPI: 1972729937 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mitchell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mitchell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mitchell

Dr. Mark Mitchell is a radiation oncology specialist in Oxnard, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mitchell performed 1,279 Medicare services across 544 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mitchell received a total of $624 from 7 pharmaceutical and/or device companies across 15 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mitchell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 1,279 Medicare services $624 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,279
Medicare services
Bottom 36% in CA for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
544
Unique beneficiaries
$312
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadoterate)
Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose.
450 $0 $43
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
227 $0 $5
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 179 $281 $450
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
153 $1,461 $4,170
Piflufolastat F-18 diagnostic injection
A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie.
99 $455 $750
Brain nuclear medicine study with metabolic evaluation
A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level.
30 $1,417 $3,765
CT scan of chest, without contrast
A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye.
26 $112 $731
MRI of leg joint, without contrast
A magnetic resonance imaging scan of a joint in the leg performed without the use of contrast dye.
22 $188 $1,270
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
21 $43 $250
MRI of brain with and without contrast
An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures.
16 $294 $2,770
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
15 $117 $857
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
14 $180 $1,300
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
14 $1,473 $4,176
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
13 $26 $76
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2020 ↗
$624
Total received (2018-2020)
Avg $208/year across 3 years
Top 30% in CA for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
7
Companies
15
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$624 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2020
$29
2019
$176
2018
$419

Payments by company (2020)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$29
Top 3 companies account for 100.0% of 2020 payments
All-time payments by company (2018-2020) ›
Merck Sharp & Dohme Corporation
$223
Genentech USA, Inc.
$148
E.R. Squibb & Sons, L.L.C.
$78
AstraZeneca Pharmaceuticals LP
$75
Pharmacyclics LLC, An AbbVie Company
$45
Amgen Inc.
$33
Array BioPharma Inc.
$22
Top 3 companies account for 71.9% of all-time payments
Associated products mentioned in payments ›
Avastin · Braftovi · Imbruvica · KEYTRUDA · Kyprolis · LYNPARZA · OPDIVO · TAGRISSO · TECENTRIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a radiation oncology specialist in Oxnard?
Compare radiation oncologists in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
35
Per 100K population
4.2
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2020
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mitchell is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mitchell experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Mitchell performed 450 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mitchell receive payments from pharmaceutical companies?
Yes. Dr. Mitchell received a total of $624 from 7 companies across 15 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mitchell's costs compare to other radiation oncologists in Oxnard?
Dr. Mitchell's average Medicare payment per service is $312. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mitchell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →